The aims of the present study were to: determine the expression of SMARCB1 in osteosarcoma; identify whether a correlation exists between SMARCB1 expression and osteosarcoma response to neoadjuvant chemotherapy; and to investigate the correlation between SMARCB1 expression and osteosarcoma patient prognosis. This evidence concerns the gene SMARCB1 and osteosarcoma.